Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line

Overexpression of efflux transporters, in human cells, is a mechanism of resistance to drug and also to chemotherapy. We found that multidrug resistance protein-4 (MRP4) overexpression has a role in reducing aspirin action in patients after bypass surgery and, very recently, we found that aspirin en...

Full description

Saved in:
Bibliographic Details
Main Authors: Isabella Massimi, Ambra Ciuffetta, Flavia Temperilli, Francesca Ferrandino, Alessandra Zicari, Fabio M. Pulcinelli, Maria Pia Felli
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/607957
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558633252028416
author Isabella Massimi
Ambra Ciuffetta
Flavia Temperilli
Francesca Ferrandino
Alessandra Zicari
Fabio M. Pulcinelli
Maria Pia Felli
author_facet Isabella Massimi
Ambra Ciuffetta
Flavia Temperilli
Francesca Ferrandino
Alessandra Zicari
Fabio M. Pulcinelli
Maria Pia Felli
author_sort Isabella Massimi
collection DOAJ
description Overexpression of efflux transporters, in human cells, is a mechanism of resistance to drug and also to chemotherapy. We found that multidrug resistance protein-4 (MRP4) overexpression has a role in reducing aspirin action in patients after bypass surgery and, very recently, we found that aspirin enhances platelet MRP4 levels through peroxisome proliferator activated receptor-α (PPARα). In the present paper, we verified whether exposure of human embryonic kidney-293 cells (Hek-293) to aspirin modifies MRP4 gene expression and its correlation with drug elimination and cell toxicity. We first investigated the effect of high-dose aspirin in Hek-293 and we showed that aspirin is able to increase cell toxicity dose-dependently. Furthermore, aspirin effects, induced at low dose, already enhance MRP4 gene expression. Based on these findings, we compared cell viability in Hek-293, after high-dose aspirin treatment, in MRP4 overexpressing cells, either after aspirin pretreatment or in MRP4 transfected cells; in both cases, a decrease of selective aspirin cell growth inhibition was observed, in comparison with the control cultures. Altogether, these data suggest that exposing cells to low nontoxic aspirin dosages can induce gene expression alterations that may lead to the efflux transporter protein overexpression, thus increasing cellular detoxification of aspirin.
format Article
id doaj-art-05c0f52772d541c6b41e1bccfdc1c777
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-05c0f52772d541c6b41e1bccfdc1c7772025-02-03T01:31:48ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/607957607957Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell LineIsabella Massimi0Ambra Ciuffetta1Flavia Temperilli2Francesca Ferrandino3Alessandra Zicari4Fabio M. Pulcinelli5Maria Pia Felli6Department of Experimental Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, Faculty of Medicine and Surgery, Sapienza University of Rome, 00161 Rome, ItalyOverexpression of efflux transporters, in human cells, is a mechanism of resistance to drug and also to chemotherapy. We found that multidrug resistance protein-4 (MRP4) overexpression has a role in reducing aspirin action in patients after bypass surgery and, very recently, we found that aspirin enhances platelet MRP4 levels through peroxisome proliferator activated receptor-α (PPARα). In the present paper, we verified whether exposure of human embryonic kidney-293 cells (Hek-293) to aspirin modifies MRP4 gene expression and its correlation with drug elimination and cell toxicity. We first investigated the effect of high-dose aspirin in Hek-293 and we showed that aspirin is able to increase cell toxicity dose-dependently. Furthermore, aspirin effects, induced at low dose, already enhance MRP4 gene expression. Based on these findings, we compared cell viability in Hek-293, after high-dose aspirin treatment, in MRP4 overexpressing cells, either after aspirin pretreatment or in MRP4 transfected cells; in both cases, a decrease of selective aspirin cell growth inhibition was observed, in comparison with the control cultures. Altogether, these data suggest that exposing cells to low nontoxic aspirin dosages can induce gene expression alterations that may lead to the efflux transporter protein overexpression, thus increasing cellular detoxification of aspirin.http://dx.doi.org/10.1155/2015/607957
spellingShingle Isabella Massimi
Ambra Ciuffetta
Flavia Temperilli
Francesca Ferrandino
Alessandra Zicari
Fabio M. Pulcinelli
Maria Pia Felli
Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
Mediators of Inflammation
title Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
title_full Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
title_fullStr Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
title_full_unstemmed Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
title_short Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
title_sort multidrug resistance protein 4 influences aspirin toxicity in human cell line
url http://dx.doi.org/10.1155/2015/607957
work_keys_str_mv AT isabellamassimi multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT ambraciuffetta multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT flaviatemperilli multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT francescaferrandino multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT alessandrazicari multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT fabiompulcinelli multidrugresistanceprotein4influencesaspirintoxicityinhumancellline
AT mariapiafelli multidrugresistanceprotein4influencesaspirintoxicityinhumancellline